doctitl prospect grant exclus licens method evalu chemotherapeut agent hollow fiber vivo doctitl agenc agenc nation institut health public health servic dhh agenc action action notic action summari summari notic accord 15 u c 209 c 1 37 cfr 404 7 1 nation institut health nih depart health human servic contempl grant exclus licens unit state practic invent embodi u patent applic serial number 08 058 154 entitl method evalu chemotherapeut agent hollow fiber vivo spectrum medic industri inc place busi san diego california patent right applic assign unit state america prospect exclus licens royalti bear compli term condit 35 u c 209 37 cfr 404 7 prospect exclus licens may grant unless within 60 day date publish notic nih receiv written evid argument establish grant licens would consist requir 35 u c 209 37 cfr 404 7 present invent relat method screen efficaci chemotherapeut agent vivo use target cell grown biocompat select permeabl macrocapsul convent method e subcutan tumor model sub renal tumor model periton model metastasi model permit one type tumor cell cell line screen per experi per anim anim subsequ sacrif analysi present method allow place sampl syngen xenogen cell laboratori anim use cell cell line grown select permeabl hollow fiber dialysi tube invent provid rapid reliabl method screen potenti chemotherapeut agent therapeut use cancer human diseas addit method allow singl experiment anim carri implant multipl site allow simultan evalu chemotherapeut agent capac reach variou physiolog compart subcutan intraperiton intra organ region advantag system classic antitumor anim model includ 1 requir smaller amount test agent assess preliminari vivo efficaci 2 rapid turn around time 3 abil test potenti activ multipl tumor type simultan experiment anim 4 reduct number experiment anim requir assess efficaci 5 possibl assess multipl treatment schedul short time frame 6 abil recov entir implant 7 lack contamin implant cell host cell 8 abil screen test agent target cell cultiv variou physiolog compart laboratori anim present invent use transgen anim determin effect transgen protein product thereof target cell line cultiv screen cell analysi make possibl assess regrowth potenti cell surviv treatment determin suscept second treatment altern chemotherapeut agent contempl field use licens would 1 preclin test anim product toxic efficaci 2 diagnost test anim human tissu specimen resist sensit altern therapeut regim spectrum medic industri intend make use sell product fall within scope patent applic research clinic diagnost market summari address address request copi patent applic inquiri comment materi relat contempl licens direct john fahner vihtel offic technolog transfer nation institut health suit 325 6011 execut blvd rockvil maryland 20852 telephon 301 4967735 extens 285 fax 301 4020220 sign confidenti agreement requir receiv copi patent applic properli file compet applic licens file respons notic treat object contempl licens written comment applic licens receiv nih offic technolog transfer within sixti 60 day notic consid date decemb 12 1994 address signer barbara mcgarey signer signjob deputi director offic technolog transfer signjob frfile fr doc 9431393 file 122194 8 45 frfile bill bill code 414001p bill